We have previously demonstrated that rats with adjuvant-induced arthritis (AA) are unable to mount a hypothalamo-pituitary-adrenal (HPA) axis response to either psychological or physical stress. In the present study we have taken male and female rats with AA and injected these with lipopolysaccharide (LPS) as an acute immune challenge and assessed the effects of this challenge at all levels of the HPA axis. We have demonstrated that, in contrast to acute stress, there is an activation of the HPA axis in male AA rats in response to acute immune challenge which occurs at all levels of the HPA axis. The hypothalamic and pituitary response to LPS is intact in the female AA rat. However, there appears to be an impaired adrenal responsiveness in the AA female given LPS. The non-AA female is able to respond to LPS suggesting that this defect is not inherent but is a reaction to the development of inflammation. This hyporesponsiveness has major implications for the ability of the organism to survive infections or immune challenges which are potentially life threatening in the absence of release of anti-inflammatory glucocorticoids from the adrenal cortex. The implications of these changes in the female on the subsequent development of the disease and the mechanisms mediating these effects may provide a better understanding of the gender differences underlying susceptibility to autoimmune diseases.
INTRODUCTION
The development of clinical symptoms in a wide variety of autoimmune disease models is accompanied by profound changes to a number of neuroendocrine systems. Changes in the hypothalamo-pituitary-adrenal (HPA) axis have been characterized in a number of disease models in both the rat and the mouse. The end-point of HPA axis activation is the release of the potent anti-inflammatory steroid corticosterone from the adrenal cortex. Failure to mount a suitable corticosterone response to an immune challenge and hence abrogate the endogenous immune response is potentially life threatening (Munck, Guyre, & Holbrook, 1984) . While normal rats are able to tolerate modest doses of cytokines such as interleukin-1 or immune activators such as lipopolysaccharide (LPS), following adrenalectomy such challenges can prove fatal (Bertini, Bianchi, & Ghezzi, 1988) . In disease models such as experimental allergic encephalomyelitis (EAE) and adjuvant-induced arthritis (AA), adrenalectomized rats develop the disease sooner, the severity is increased, and if allowed to progress the disease rapidly becomes fatal (MacPhee, Antoni, & Mason, 1989; Harbuz, Rees, & Lightman, 1993) .
Under normal conditions the response to acute stress involves an increase in corticotropin-releasing factor (CRF) release from the external zone of the median eminence into the hypophysial portal blood which stimulates ACTH release from the
